PHASE 3 RANDOMIZED STUDY OF DARATUMUMAB (DARA) MONOTHERAPY VERSUS ACTIVE MONITORING IN PATIENTS (PTS) WITH HIGH-RISK SMOLDERING MULTIPLE MYELOMA (SMM): PRIMARY RESULTS OF THE AQUILA STUDY


Por: Dimopoulos, MA, Voorhees, PM, Schjesvold, F, Cohen, YC, Hungria, V, Sandhu, I, Lindsay, J, Baker, RI, Suzuki, K, Kosugi, H, Levin, M, Beksac, M, Stockerl-Goldstein, K, Oriol, A, Mikala, G, Garate, G, Theunissen, K, Spicka, I, Mylin, AK, Bringhen, S, Uttervall, K, Pula, B, Medvedova, E, Cowan, AJ, Moreau, P, Mateos, MV, Goldschmidt, H, Ahmadi, T, Sha, L, Rousseau, E, Li, L, Dennis, RM, Carson, R and Rajkumar, SV

Publicada: 1 abr 2025
Resumen:


Filiaciones:
Dimopoulos, MA:
 Natl & Kapodistrian Univ Athens, Alexandra Gen Hosp, Athens, Greece

Voorhees, PM:
 Wake Forest Univ, Sch Med, Atrium Hlth, Levine Canc Inst, Winston Salem, NC USA

Schjesvold, F:
 Oslo Univ Hosp, Dept Hematol, Oslo Myeloma Ctr, Oslo, Norway

Cohen, YC:
 Tel Aviv Sourasky Ichilov Med Ctr, Tel Aviv, Israel

 Tel Aviv Univ, Tel Aviv, Israel

Hungria, V:
 Clin Med Sao Germano, Sao Paulo, Brazil

Sandhu, I:
 Univ Alberta, Cross Canc Inst, Edmonton, AB, Canada

Lindsay, J:
 Kent & Canterbury Hosp, Canterbury, Kent, England

Baker, RI:
 Murdoch Univ, Perth Blood Inst, Murdoch, WA, Australia

Suzuki, K:
 Japanese Red Cross Med Ctr, Tokyo, Japan

Kosugi, H:
 Ogaki Municipal Hosp, Ogaki, Japan

Levin, M:
 Albert Schwitzer Hosp, Dordrecht, Netherlands

Beksac, M:
 Ankara Univ, Ankara, Turkiye

Stockerl-Goldstein, K:
 Washington Univ, Sch Med, St Louis, MO USA

:
 Hosp Badalona Germans Trias & Pujol, Inst Catala Oncol, Barcelona, Spain

 Hosp Badalona Germans Trias & Pujol, Inst Josep Carreras, Barcelona, Spain

Mikala, G:
 South Pest Cent Hosp, Natl Inst Hematol & Infect Dis, Budapest, Hungary

Garate, G:
 Hosp Aleman, Buenos Aires, DF, Argentina

Theunissen, K:
 Jessa Hosp, Hasselt, Belgium

Spicka, I:
 Charles Univ Prague, Prague, Czech Republic

 Gen Hosp, Prague, Czech Republic

Mylin, AK:
 Univ Copenhagen, Rigshosp, Copenhagen, Denmark

Bringhen, S:
 AOU Citta Salute & Sci Torino, SSD Clin Trials Oncol Ematol Mieloma Multiplo, Turin, Italy

Uttervall, K:
 Karolinska Univ Hosp, Med Unit Hematol, Stockholm, Sweden

Pula, B:
 Inst Hematol & Transfus Med, Warsaw, Poland

Medvedova, E:
 Oregon Hlth & Sci Univ, Knight Canc Inst, Portland, OR USA

Cowan, AJ:
 Univ Washington, Seattle, WA USA

 Fred Hutchinson Canc Ctr, Seattle, WA USA

Moreau, P:
 Univ Hosp Hotel Dieu, Paris, France

Mateos, MV:
 Univ Hosp Salamanca, IBSAL, Canc Res Ctr, IBMCC,USAL,CSIC, Salamanca, Spain

Goldschmidt, H:
 Univ Hosp Heidelberg, GMMG Study Grp, Internal Med 5, Heidelberg, Germany

Ahmadi, T:
 Genmab US Inc, Cambridge, MA USA

Sha, L:
 Janssen Res & Dev, Beijing, Peoples R China

Rousseau, E:
 Janssen Res & Dev, Beerse, Belgium

Li, L:
 Janssen Res & Dev, Beijing, Peoples R China

Dennis, RM:
 Janssen Res & Dev, Raritan, NJ USA

Carson, R:
 Janssen Res & Dev, Raritan, NJ USA

Rajkumar, SV:
 Mayo Clin, Rochester, MN USA
ISSN: 03906078





HAEMATOLOGICA
Editorial
Ferrata Storti Foundation, VIA GIUSEPPE BELLI 4, 27100 PAVIA, ITALY, Italia
Tipo de documento: Meeting Abstract
Volumen: 110 Número:
Páginas: 26-26
WOS Id: 001728539100046

MÉTRICAS